Related Experiment Video

Updated: Apr 26, 2026

Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source
06:37

Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source

Published on: February 7, 2013

16.1K

HMGB1 as a drug target in staphylococcal pneumonia

Mitchell P Fink

    Critical Care (London, England)
    |July 17, 2014
    PubMed

    Insights

    High mobility group box 1 (HMGB1) is implicated in staphylococcal pneumonia. Neutralizing HMGB1 reduced lung damage in mice, suggesting it

    Area of Science:

    • Immunology
    • Molecular Biology
    • Pulmonary Medicine

    Background:

    • High mobility group box 1 (HMGB1) is a nuclear protein involved in gene regulation.
    • Extracellular HMGB1 acts as a pro-inflammatory mediator.
    • Staphylococcus aureus pneumonia causes significant pulmonary damage.

    Purpose of the Study:

    • To investigate the role of HMGB1 in Staphylococcus aureus pneumonia.
    • To evaluate HMGB1 as a potential therapeutic target for staphylococcal pneumonia.

    Main Methods:

    • Utilized a murine model of pneumonia induced by Staphylococcus aureus.
    • Administered a neutralizing anti-HMGB1 antibody to assess its therapeutic effect.
    • Evaluated pulmonary damage in treated and control groups.

    Main Results:

    • Treatment with an anti-HMGB1 antibody ameliorated pulmonary damage in the murine pneumonia model.
    • HMGB1 neutralization demonstrated a protective effect against Staphylococcus aureus-induced lung injury.

    Conclusions:

    • HMGB1 plays a critical role in the pathogenesis of staphylococcal pneumonia.
    • Targeting HMGB1 with neutralizing antibodies represents a promising therapeutic strategy for staphylococcal pneumonia.
    • Further validation in large animal models is recommended before clinical translation.

    More Related Videos

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

    Published on: January 2, 2017

    17.4K
    Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth09:10

    Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

    Published on: January 7, 2022

    1.8K

    Related Concept Videos

    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
    206
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
    84
    Inhibitors of Bacterial Protein Synthesis01:25

    Inhibitors of Bacterial Protein Synthesis

    Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
    99
    Inhibitors of Gram-positive Cell Wall Synthesis01:23

    Inhibitors of Gram-positive Cell Wall Synthesis

    Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
    179
    Staphylococcal Skin Infections01:29

    Staphylococcal Skin Infections

    Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
    133
    GPCRs Regulate Adenylyl Cylase Activity01:09

    GPCRs Regulate Adenylyl Cylase Activity

    Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
    6.8K